WEDNESDAY, Oct. 18, 2023 (HealthDay News) — COVID infection can raise the risk of a rare immune system attack on the body’s nerves — but vaccination might protect against it, a large new study suggests. The study, of more than 3 million Israeli adults and teenagers, found that COVID infectionContinue Reading
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — An inexpensive medication long used for depression and migraines now has a clinical trial to back up its off-label use for another condition that lowers quality of life: irritable bowel syndrome (IBS). In the study, British researchers found that those taking amitriptyline wereContinue Reading
MONDAY, Oct. 16, 2023 (HealthDay News) — The drugstore chain Rite Aid has filed for Chapter 11 bankruptcy, due largely to competition and thousands of lawsuits for its role in allegedly filling unlawful opioid prescriptions. The company filed a notice Thursday with the U.S. Securities and Exchange Commission saying itContinue Reading
MONDAY, Oct. 16, 2023 (HealthDay News) — A new trial demonstrates the power of the diabetes drug Mounjaro in fighting obesity, helping folks who used the medication lose about 60 pounds. “In this study, people who added tirzepatide [Mounjaro] to diet and exercise saw greater, longer-lasting weight reduction than thoseContinue Reading
FRIDAY, Oct. 13, 2023 (HealthDay News) — Following a rocky rollout, more than 7 million Americans have now gotten the newly updated COVID vaccines. Unfortunately, that’s still lagging behind the number who sought booster shots last fall. For the the first updated boosters, 18 million people had received their shotsContinue Reading
THURSDAY, Oct. 12, 2023 (HealthDay News) — Most folks know that certain antidepressants have to be taken for a few weeks before people start seeing improvement, and now a new study sheds light on that delay. Scientists have discovered this is because of physical changes in the brain that unfoldContinue Reading
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — New research points to the potential of a COVID-19 vaccine delivered through the nose. The phase 1 clinical trial showed that the product, administered nasally in two doses, delivered a significant immune response to multiple COVID variants. Called CoviLiv, the vaccine was testedContinue Reading
WEDNESDAY, Oct. 11, 2023 (HealthDay News) — Cigarette makers are using synthetic menthol substitutes in what appears to be an effort to skirt a looming federal menthol ban, researchers say. The menthol flavor appeals to younger and newer smokers, according to investigators at Duke Health in Durham, N.C., and YaleContinue Reading
TUESDAY, Oct. 10, 2023 (HealthDay News) — As many doctors and patients hail the advent of weight-loss drugs like Ozempic and Wegovy as the perfect fix for obesity, some experts are urging caution. The drugs are not well-tolerated by everyone struggling with obesity. For some folks, the weight piles backContinue Reading
MONDAY, Oct. 9, 2023 (HealthDay News) — Exercise has been dubbed “nature’s antidepressant” by doctors for years, and now a new study confirms the notion. The finding follows a four-month look at the impact that running had on anxiety and depression when compared to a common antidepressant. SSRIs (selective serotoninContinue Reading